Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Ibrutinib, a Bruton's tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma.

Wang J, Liu X, Hong Y, Wang S, Chen P, Gu A, Guo X, Zhao P.

J Exp Clin Cancer Res. 2017 Jul 17;36(1):96. doi: 10.1186/s13046-017-0549-6.

2.

Autophagy and multidrug resistance in cancer.

Li YJ, Lei YH, Yao N, Wang CR, Hu N, Ye WC, Zhang DM, Chen ZS.

Chin J Cancer. 2017 Jun 24;36(1):52. doi: 10.1186/s40880-017-0219-2. Review.

3.

Autophagic Mechanism in Anti-Cancer Immunity: Its Pros and Cons for Cancer Therapy.

Li YY, Feun LG, Thongkum A, Tu CH, Chen SM, Wangpaichitr M, Wu C, Kuo MT, Savaraj N.

Int J Mol Sci. 2017 Jun 19;18(6). pii: E1297. doi: 10.3390/ijms18061297. Review.

4.

Hormonally up-regulated neu-associated kinase: A novel target for breast cancer progression.

Zambrano JN, Neely BA, Yeh ES.

Pharmacol Res. 2017 May;119:188-194. doi: 10.1016/j.phrs.2017.02.007. Epub 2017 Feb 9. Review.

PMID:
28189783
5.

Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer.

Eritja N, Chen BJ, Rodríguez-Barrueco R, Santacana M, Gatius S, Vidal A, Martí MD, Ponce J, Bergadà L, Yeramian A, Encinas M, Ribera J, Reventós J, Boyd J, Villanueva A, Matias-Guiu X, Dolcet X, Llobet-Navàs D.

Autophagy. 2017 Mar 4;13(3):608-624. doi: 10.1080/15548627.2016.1271512. Epub 2017 Jan 5.

6.
7.

Inhibiting autophagy increases epirubicin's cytotoxicity in breast cancer cells.

Guo W, Wang Y, Wang Z, Wang YP, Zheng H.

Cancer Sci. 2016 Nov;107(11):1610-1621. doi: 10.1111/cas.13059. Epub 2016 Nov 4.

8.

Identification of breast cancer cell subtypes sensitive to ATG4B inhibition.

Bortnik S, Choutka C, Horlings HM, Leung S, Baker JH, Lebovitz C, Dragowska WH, Go NE, Bally MB, Minchinton AI, Gelmon KA, Gorski SM.

Oncotarget. 2016 Oct 11;7(41):66970-66988. doi: 10.18632/oncotarget.11408.

9.
10.

ATG9A loss confers resistance to trastuzumab via c-Cbl mediated Her2 degradation.

Nunes J, Zhang H, Angelopoulos N, Chhetri J, Osipo C, Grothey A, Stebbing J, Giamas G.

Oncotarget. 2016 May 10;7(19):27599-612. doi: 10.18632/oncotarget.8504.

11.

Co-Targeting of JNK and HUNK in Resistant HER2-Positive Breast Cancer.

Phelps-Polirer K, Abt MA, Smith D, Yeh ES.

PLoS One. 2016 Apr 5;11(4):e0153025. doi: 10.1371/journal.pone.0153025. eCollection 2016.

12.

Autophagy and Apoptotic Crosstalk: Mechanism of Therapeutic Resistance in HER2-Positive Breast Cancer.

Zambrano J, Yeh ES.

Breast Cancer (Auckl). 2016 Mar 13;10:13-23. doi: 10.4137/BCBCR.S32791. eCollection 2016. Review.

13.

Enhanced autophagy reveals vulnerability of P-gp mediated epirubicin resistance in triple negative breast cancer cells.

Zhang LH, Yang AJ, Wang M, Liu W, Wang CY, Xie XF, Chen X, Dong JF, Li M.

Apoptosis. 2016 Apr;21(4):473-88. doi: 10.1007/s10495-016-1214-9.

14.

p130Cas scaffold protein regulates ErbB2 stability by altering breast cancer cell sensitivity to autophagy.

Bisaro B, Sciortino M, Colombo S, Camacho Leal MP, Costamagna A, Castellano I, Montemurro F, Rossi V, Valabrega G, Turco E, Defilippi P, Cabodi S.

Oncotarget. 2016 Jan 26;7(4):4442-53. doi: 10.18632/oncotarget.6710.

15.

Efficacy and mechanism of action of the tyrosine kinase inhibitors gefitinib, lapatinib and neratinib in the treatment of HER2-positive breast cancer: preclinical and clinical evidence.

Segovia-Mendoza M, González-González ME, Barrera D, Díaz L, García-Becerra R.

Am J Cancer Res. 2015 Aug 15;5(9):2531-61. eCollection 2015. Review.

16.

Autophagy Protects from Trastuzumab-Induced Cytotoxicity in HER2 Overexpressing Breast Tumor Spheroids.

Rodríguez CE, Reidel SI, Bal de Kier Joffé ED, Jasnis MA, Fiszman GL.

PLoS One. 2015 Sep 11;10(9):e0137920. doi: 10.1371/journal.pone.0137920. eCollection 2015.

17.

Role of GRP78 in promoting therapeutic-resistant breast cancer.

Cook KL, Clarke R.

Future Med Chem. 2015 Aug;7(12):1529-34. doi: 10.4155/FMC.15.80. Epub 2015 Aug 24.

18.

Chloroquine enhances gefitinib cytotoxicity in gefitinib-resistant nonsmall cell lung cancer cells.

Tang MC, Wu MY, Hwang MH, Chang YT, Huang HJ, Lin AM, Yang JC.

PLoS One. 2015 Mar 25;10(3):e0119135. doi: 10.1371/journal.pone.0119135. eCollection 2015.

19.

Elevated NIBP/TRAPPC9 mediates tumorigenesis of cancer cells through NFκB signaling.

Zhang Y, Liu S, Wang H, Yang W, Li F, Yang F, Yu D, Ramsey FV, Tuszyski GP, Hu W.

Oncotarget. 2015 Mar 20;6(8):6160-78.

20.

Autophagy inhibition re-sensitizes pulse stimulation-selected paclitaxel-resistant triple negative breast cancer cells to chemotherapy-induced apoptosis.

Wen J, Yeo S, Wang C, Chen S, Sun S, Haas MA, Tu W, Jin F, Guan JL.

Breast Cancer Res Treat. 2015 Feb;149(3):619-29. doi: 10.1007/s10549-015-3283-9. Epub 2015 Feb 1.

Supplemental Content

Support Center